| Product NDC: | 0169-7703 |
| Proprietary Name: | Norditropin |
| Non Proprietary Name: | somatropin |
| Active Ingredient(s): | 30 mg/3mL & nbsp; somatropin |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0169-7703 |
| Labeler Name: | Novo Nordisk |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021148 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090330 |
| Package NDC: | 0169-7703-11 |
| Package Description: | 1 SYRINGE in 1 CARTON (0169-7703-11) > 3 mL in 1 SYRINGE |
| NDC Code | 0169-7703-11 |
| Proprietary Name | Norditropin |
| Package Description | 1 SYRINGE in 1 CARTON (0169-7703-11) > 3 mL in 1 SYRINGE |
| Product NDC | 0169-7703 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | somatropin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090330 |
| Marketing Category Name | NDA |
| Labeler Name | Novo Nordisk |
| Substance Name | SOMATROPIN |
| Strength Number | 30 |
| Strength Unit | mg/3mL |
| Pharmaceutical Classes | Recombinant Human Growth Hormone [EPC],Recombinant Human Growth Hormones [Chemical/Ingredient] |